| AASLD

Home

Retraction statement: Redox‐dependent regulation of hepatocyte absent in melanoma 2 inflammasome activation in sterile liver injury in mice

Read more about Retraction statement: Redox‐dependent regulation of hepatocyte absent in melanoma 2 inflammasome activation in sterile liver injury in mice

4 September 2019

Tumor‐Derived Peptidoglycan Recognition Protein 2 Predicts Survival and Antitumor Immune Responses in Hepatocellular Carcinoma

Read more about Tumor‐Derived Peptidoglycan Recognition Protein 2 Predicts Survival and Antitumor Immune Responses in Hepatocellular Carcinoma

Zongyi Yang, Jia Feng, Li Xiao, Xi Chen, Yuanfei Yao, Yiqun Li, Yu Tang, Shuai Zhang, Min Lu, Yu Qian, Hongjin Wu, Ming Shi – 3 September 2019

Issue Information

Read more about Issue Information

3 September 2019

Toward Elimination of Hepatitis C Infection: How Best to Address Gaps in the Cascade of Care?

Read more about Toward Elimination of Hepatitis C Infection: How Best to Address Gaps in the Cascade of Care?

Vijay Prabhakar, Paul Y. Kwo – 3 September 2019

R‐spondin 2 Drives Liver Tumor Development in a Yes‐Associated Protein‐Dependent Manner

Read more about R‐spondin 2 Drives Liver Tumor Development in a Yes‐Associated Protein‐Dependent Manner

Caitlin B. Conboy, Germán L. Vélez‐Reyes, Barbara R. Tschida, Hsiangyu Hu, Gabriel Kaufmann, Nicholas Koes, Bryant Keller, Clara Alsinet, Helena Cornellà, Roser Pinyol, Juan E. Abrahante, Nuri A. Temiz, Michael A. Linden, Khalid Amin, Timothy P. Kuka, Vincent W. Keng, Josep M. Llovet, Timothy K. Starr, David A. Largaespada – 3 September 2019 – Each year, more than 25,000 people succumb to liver cancer in the United States, and this neoplasm represents the second cause of cancer‐related death globally.